Terms: = Brain cancer AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12
834 results:
1. Plasma Lipidomic Profiling Identifies Elevated Triglycerides as Potential Risk Factor in Chemotherapy-Induced Peripheral Neuropathy.
Yeung N; Li T; Lin HM; Timmins HC; Goldstein D; Harrison M; Friedlander M; Mahon KL; Giles C; Meikle PJ; Park SB; Horvath LG
JCO Precis Oncol; 2024 Apr; 8():e2300690. PubMed ID: 38691814
[TBL] [Abstract] [Full Text] [Related]
2. Headache alleviation with nasal irrigation following endoscopic endonasal surgery for pituitary adenomas.
Gu J; Chen X; Cheng X; Zou Y; Deng Z; Li D; Zhou Z; Jiang X
BMC Endocr Disord; 2024 Apr; 24(1):45. PubMed ID: 38622616
[TBL] [Abstract] [Full Text] [Related]
3. [Expression of immune checkpoints PD-L1, ctla4, LAG3 in the microenvironment of colon adenocarcinoma depending on MMR status].
Naumov SS; Krakhmal NV; Tashireva LA; Vtorushin SV
Arkh Patol; 2024; 86(2):6-13. PubMed ID: 38591901
[TBL] [Abstract] [Full Text] [Related]
4. [
Pruis IJ; Verburg FA; Balvers RK; Harteveld AA; Feelders RA; Vernooij MW; Smits M; Neggers SJCMM; Veldhuijzen van Zanten SEM
J Nucl Med; 2024 May; 65(5):688-692. PubMed ID: 38514085
[TBL] [Abstract] [Full Text] [Related]
5. Relevance of mutations in protein deubiquitinases genes and
Pękul M; Szczepaniak M; Kober P; Rusetska N; Mossakowska BJ; Baluszek S; Kowalik A; Maksymowicz M; Zieliński G; Kunicki J; Witek P; Bujko M
Front Endocrinol (Lausanne); 2024; 15():1302667. PubMed ID: 38487343
[TBL] [Abstract] [Full Text] [Related]
6. Autoimmune Disorders Associated With Surgical Remission of Cushing's Disease : A Cohort Study.
Nyanyo DD; Mikamoto M; Galbiati F; Remba-Shapiro I; Bode K; Schoenfeld S; Jones PS; Swearingen B; Nachtigall LB
Ann Intern Med; 2024 Mar; 177(3):315-323. PubMed ID: 38373302
[TBL] [Abstract] [Full Text] [Related]
7. Neoadjuvant Immunotherapy With Ipilimumab Plus Nivolumab in Mismatch Repair Deficient/Microsatellite Instability-High Colorectal cancer: A Preliminary Report of Case Series.
Pan T; Yang H; Wang WY; Rui YY; Deng ZJ; Chen YC; Liu C; Hu H
Clin Colorectal Cancer; 2024 Mar; 23(1):104-110. PubMed ID: 38336555
[TBL] [Abstract] [Full Text] [Related]
8. Recurrent Cushing's Disease Caused by a TPIT-Lineage Densely Granulated Corticotroph Pituitary Neuroendocrine Tumor: A Case Report.
Wu W; Fu X; Guo W; Chen H
Neuro Endocrinol Lett; 2024 Jan; 45(1):76-80. PubMed ID: 38295430
[TBL] [Abstract] [Full Text] [Related]
9. Spatial and temporal heterogeneity of tumor immune microenvironment between primary tumor and brain metastases in NSCLC.
Liu JS; Cai YX; He YZ; Xu J; Tian SF; Li ZQ
BMC Cancer; 2024 Jan; 24(1):123. PubMed ID: 38267913
[TBL] [Abstract] [Full Text] [Related]
10. Macro CD5L
Lu JC; Wu LL; Sun YN; Huang XY; Gao C; Guo XJ; Zeng HY; Qu XD; Chen Y; Wu D; Pei YZ; Meng XL; Zheng YM; Liang C; Zhang PF; Cai JB; Ding ZB; Yang GH; Ren N; Huang C; Wang XY; Gao Q; Sun QM; Shi YH; Qiu SJ; Ke AW; Shi GM; Zhou J; Sun YD; Fan J
Nat Commun; 2024 Jan; 15(1):621. PubMed ID: 38245530
[TBL] [Abstract] [Full Text] [Related]
11. The Association of Immune Cell Infiltration with Metastasis Location in De Novo Metastatic Triple Negative Breast cancer: A Multicenter Cross-Sectional Study in Indonesia.
Tenggara JB; Rachman A; Prihartono J; Lisnawati L; Panigoro SS; Heriyanto DS; Steven R; Tandarto K; Juanputra S; Sudoyo AW
Acta Med Indones; 2023 Oct; 55(4):376-384. PubMed ID: 38213050
[TBL] [Abstract] [Full Text] [Related]
12. An overview of up-and-coming immune checkpoint inhibitors for pancreatic cancer.
Mahadevia H; Uson Junior PLS; Wang J; Borad M; Babiker H
Expert Opin Pharmacother; 2024; 25(1):79-90. PubMed ID: 38193476
[TBL] [Abstract] [Full Text] [Related]
13. Evaluating the efficacy of combination and single-agent immunotherapies in real-world patterns of disease progression and survival of metastatic melanoma patients.
Ko B; Tao K; Brennan L; Rakhade S; Chan CX; Moone JY; Zhu R; Sher A; Wang S; Bracero Y; Fullerton B; McLellan B; Geskin LJ; Saenger YM
Melanoma Res; 2024 Apr; 34(2):134-141. PubMed ID: 38181115
[TBL] [Abstract] [Full Text] [Related]
14. Concentrations of S100B and neurofilament light chain in blood as biomarkers for checkpoint inhibitor-induced CNS inflammation.
Bjursten S; Zhao Z; Al Remawi H; Studahl M; Pandita A; Simrén J; Zetterberg H; Lundell AC; Rudin A; Ny L; Levin M
EBioMedicine; 2024 Feb; 100():104955. PubMed ID: 38171113
[TBL] [Abstract] [Full Text] [Related]
15. Analysis of Histomorphologic/Molecular Association and Immune Checkpoint Regulators in Epithelioid Glioblastoma and Pleomorphic Xanthoastrocytoma: Are These Tumors Potential Candidates for Immune Checkpoint Blockade?
Mahajan S; Singh J; Dandapath I; Jha P; Chaturvedi S; Ahuja A; Bhardwaj M; Saran R; Garg A; Sharma MC; Manjunath N; Suri A; Sarkar C; Suri V
Appl Immunohistochem Mol Morphol; 2024 Feb; 32(2):84-95. PubMed ID: 38158760
[TBL] [Abstract] [Full Text] [Related]
16. Face to face among different chemo-immunotherapy combinations in the first line treatment of patients with advanced non-small cell lung cancer: Results of an international expert panel meeting by the italian association of thoracic oncology (AIOT).
Gridelli C; Peters S; Mok T; Garassino M; Paz-Ares L; Attili I; de Marinis F
Lung Cancer; 2024 Jan; 187():107441. PubMed ID: 38141488
[TBL] [Abstract] [Full Text] [Related]
17. Imaging for assessment of cancer treatment response to immune checkpoint inhibitors can be complementary in identifying hypophysitis.
Galligan A; Iravani A; Lasocki A; Wallace R; Weppler AM; Sachithanandan N; Chiang C; Colman PG; Wentworth J; Spain L; Au-Yeung G; Lee B; Kay TWH; Hicks RJ; Sandhu S; Krishnamurthy B
Front Endocrinol (Lausanne); 2023; 14():1295865. PubMed ID: 38093958
[TBL] [Abstract] [Full Text] [Related]
18. Radiogenomic landscape: Assessment of specific phagocytosis regulators in lower-grade gliomas.
Maimaiti A; Abulaiti A; Tang B; Dilixiati Y; Li X; Yakufu S; Wang Y; Jiang L; Shao H
Exp Biol Med (Maywood); 2023 Dec; 248(23):2289-2303. PubMed ID: 38062999
[TBL] [Abstract] [Full Text] [Related]
19. Predictive value of CCL2 in the prognosis and immunotherapy response of glioblastoma multiforme.
Deng L; Ren J; Li B; Wang Y; Jiang N; Wang Y; Cui H
BMC Genomics; 2023 Dec; 24(1):746. PubMed ID: 38057698
[TBL] [Abstract] [Full Text] [Related]
20. Differential requirements for CD4+ T cells in the efficacy of the anti-PD-1+LAG-3 and anti-PD-1+ctla-4 combinations in melanoma flank and brain metastasis models.
Phadke MS; Li J; Chen Z; Rodriguez PC; Mandula JK; Karapetyan L; Forsyth PA; Chen YA; Smalley KSM
J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38056899
[TBL] [Abstract] [Full Text] [Related]
[Next]